These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 27085875)

  • 1. Translating microRNAs into biomarkers: What is new for pediatric cancer?
    de Carvalho IN; de Freitas RM; Vargas FR
    Med Oncol; 2016 May; 33(5):49. PubMed ID: 27085875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
    Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
    Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic and therapeutic application of microRNAs in breast cancer: Tissue and circulating microRNAs.
    Bahrami A; Aledavood A; Anvari K; Hassanian SM; Maftouh M; Yaghobzade A; Salarzaee O; ShahidSales S; Avan A
    J Cell Physiol; 2018 Feb; 233(2):774-786. PubMed ID: 28109133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiling cell-free and circulating miRNA: a clinical diagnostic tool for different cancers.
    Chakraborty C; Das S
    Tumour Biol; 2016 May; 37(5):5705-14. PubMed ID: 26831657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical relevance of circulating, exosomal miRNAs as biomarkers for cancer.
    Schwarzenbach H
    Expert Rev Mol Diagn; 2015; 15(9):1159-69. PubMed ID: 26202667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosome-encapsulated microRNAs as circulating biomarkers for breast cancer.
    Joyce DP; Kerin MJ; Dwyer RM
    Int J Cancer; 2016 Oct; 139(7):1443-8. PubMed ID: 27170104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating miRNAs in cancer: from detection to therapy.
    Wang WT; Chen YQ
    J Hematol Oncol; 2014 Dec; 7():86. PubMed ID: 25476853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Relevance of Circulating, Cell-Free and Exosomal microRNAs in Plasma and Serum of Breast Cancer Patients.
    Schwarzenbach H
    Oncol Res Treat; 2017; 40(7-8):423-429. PubMed ID: 28683441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal miRNAs as novel cancer biomarkers: Challenges and opportunities.
    Salehi M; Sharifi M
    J Cell Physiol; 2018 Sep; 233(9):6370-6380. PubMed ID: 29323722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNAs: potential biomarkers for common malignancies.
    Khoury S; Tran N
    Biomark Med; 2015; 9(2):131-51. PubMed ID: 25689901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating exosomes and exosomal microRNAs as biomarkers in gastrointestinal cancer.
    Nedaeinia R; Manian M; Jazayeri MH; Ranjbar M; Salehi R; Sharifi M; Mohaghegh F; Goli M; Jahednia SH; Avan A; Ghayour-Mobarhan M
    Cancer Gene Ther; 2017 Feb; 24(2):48-56. PubMed ID: 27982021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs in extracellular vesicles: potential cancer biomarkers.
    Kinoshita T; Yip KW; Spence T; Liu FF
    J Hum Genet; 2017 Jan; 62(1):67-74. PubMed ID: 27383658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating exosomal microRNAs as emerging non-invasive clinical biomarkers in heart failure: Mega bio-roles of a nano bio-particle.
    Zhou R; Wang L; Zhao G; Chen D; Song X; Momtazi-Borojeni AA; Yuan H
    IUBMB Life; 2020 Dec; 72(12):2546-2562. PubMed ID: 33053610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current State of Circulating MicroRNAs as Cancer Biomarkers.
    He Y; Lin J; Kong D; Huang M; Xu C; Kim TK; Etheridge A; Luo Y; Ding Y; Wang K
    Clin Chem; 2015 Sep; 61(9):1138-55. PubMed ID: 26319452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel method to detect microRNAs using chip-based QuantStudio 3D digital PCR.
    Conte D; Verri C; Borzi C; Suatoni P; Pastorino U; Sozzi G; Fortunato O
    BMC Genomics; 2015 Oct; 16():849. PubMed ID: 26493562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.
    Sohn W; Kim J; Kang SH; Yang SR; Cho JY; Cho HC; Shim SG; Paik YH
    Exp Mol Med; 2015 Sep; 47(9):e184. PubMed ID: 26380927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomal MiRNAs in Pediatric Cancers.
    Galardi A; Colletti M; Di Paolo V; Vitullo P; Antonetti L; Russo I; Di Giannatale A
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31533332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating MicroRNAs as Biomarkers in Biliary Tract Cancers.
    Letelier P; Riquelme I; Hernández AH; Guzmán N; Farías JG; Roa JC
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27223281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of known and novel germ cell cancer-specific (embryonic) miRs in serum by high-throughput profiling.
    Rijlaarsdam MA; van Agthoven T; Gillis AJ; Patel S; Hayashibara K; Lee KY; Looijenga LH
    Andrology; 2015 Jan; 3(1):85-91. PubMed ID: 25382245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomes-microRNAs interacted with gastric cancer and its microenvironment: a mini literature review.
    Deng Z; Wu J; Xu S; Chen F; Zhang Z; Jin A; Wang J
    Biomark Med; 2020 Feb; 14(2):141-150. PubMed ID: 32064893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.